Drew is a Principal and the Medical Officer at Pappas Capital, a Durham based life science venture capital firm. Prior to joining Pappas Capital, he was a resident physician in surgery at Washington University in St. Louis. Drew received MD and MBA degrees from the University of North Carolina at Chapel Hill and a BS in Neuroscience from Duke University. Drew currently serves as a board observer for Glycomine Inc., CuraSen Therapeutics and Veralox Therapeutics.